BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8995553)

  • 1. DNA ploidy and expression of p53 and C-erbB-2 in extramammary Paget's disease of the vulva.
    Scheistrøen M; Tropé C; Kaern J; Pettersen EO; Alfsen GC; Nesland JM
    Gynecol Oncol; 1997 Jan; 64(1):88-92. PubMed ID: 8995553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva.
    Black D; Tornos C; Soslow RA; Awtrey CS; Barakat RR; Chi DS
    Gynecol Oncol; 2007 Mar; 104(3):547-50. PubMed ID: 17067662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathologic study of 30 patients with Paget's disease of the vulva.
    Kodama S; Kaneko T; Saito M; Yoshiya N; Honma S; Tanaka K
    Gynecol Oncol; 1995 Jan; 56(1):63-70. PubMed ID: 7821849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paget's disease of the vulva: pathology, pattern of involvement, and prognosis.
    Parker LP; Parker JR; Bodurka-Bevers D; Deavers M; Bevers MW; Shen-Gunther J; Gershenson DM
    Gynecol Oncol; 2000 Apr; 77(1):183-9. PubMed ID: 10739709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in Paget's disease of the vulva: a study of 21 cases.
    Crawford D; Nimmo M; Clement PB; Thomson T; Benedet JL; Miller D; Gilks CB
    Int J Gynecol Pathol; 1999 Oct; 18(4):351-9. PubMed ID: 10542944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paget disease of the vulva. 36 cases].
    Molinie V; Paniel BJ; Lessana-Leibowitch M; Moyal-Barracco M; Pelisse M; Escande JP
    Ann Dermatol Venereol; 1993; 120(8):522-7. PubMed ID: 8304708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extramammary Paget's disease of the vulva: metastases to the bone marrow in the absence of an underlying adenocarcinoma--case report and literature review.
    Cappuccini F; Tewari K; Rogers LW; DiSaia PJ
    Gynecol Oncol; 1997 Jul; 66(1):146-50. PubMed ID: 9234936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic and immunohistochemical features of vulvar Paget diseases].
    Lu H; Zhu G; Lu H
    Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):156-8. PubMed ID: 11263186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar Paget's disease. Is immunocytochemistry helpful in assessing the surgical margins?
    Ganjei P; Giraldo KA; Lampe B; Nadji M
    J Reprod Med; 1990 Nov; 35(11):1002-4. PubMed ID: 1703577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paget disease of the vulva: a study of 56 cases.
    Shaco-Levy R; Bean SM; Vollmer RT; Jewell E; Jones EL; Valdes CL; Bentley RC; Selim MA; Robboy SJ
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):86-91. PubMed ID: 19969410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microinvasive Paget's disease.
    Ewing T; Sawicki J; Ciaravino G; Rumore GJ
    Gynecol Oncol; 2004 Dec; 95(3):755-8. PubMed ID: 15581999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and HER-2/neu overexpression in ovarian borderline tumors.
    Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR
    Gynecol Oncol; 1997 May; 65(2):218-24. PubMed ID: 9159328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramammary Paget's disease of the vulva.
    Fishman DA; Chambers SK; Schwartz PE; Kohorn EI; Chambers JT
    Gynecol Oncol; 1995 Feb; 56(2):266-70. PubMed ID: 7896196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
    Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW
    Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paget's disease of the vulva: evaluation of recurrence relative to symptom duration, volumetric excision of lesion, and surgical margin status.
    Roh HJ; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Acta Obstet Gynecol Scand; 2010 Jul; 89(7):962-5. PubMed ID: 20583939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulvar and breast Paget's disease with synchronous underlying cancer: a unique association.
    Spiliopoulos D; Spiliopoulos M; Dandolu V; Mastrogiannis D
    Arch Gynecol Obstet; 2009 Aug; 280(2):313-5. PubMed ID: 19112575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2/neu expression in Paget disease of the vulva and the female breast.
    Brummer O; Stegner HE; Böhmer G; Kühnle H; Petry KU
    Gynecol Oncol; 2004 Nov; 95(2):336-40. PubMed ID: 15491754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous Paget's disease of the vulva and breast.
    Popiolek DA; Hajdu SI; Gal D
    Gynecol Oncol; 1998 Oct; 71(1):137-40. PubMed ID: 9784335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.